In 62 patients with symptomatic intracranial atherosclerotic stenosis, adding alirocumab to high-intensity statin gave greater median stenosis reduction at 6 months than statin alone (7.1% vs −1.2%). Recurrent stroke did not differ significantly (5% vs 13%).
RCTn = 62
Pan et al. Add-On PCSK9 Inhibitor Therapy for Acute Stroke Attributable to Intracranial Atherosclerosis: A Randomized Clinical Trial